Literature DB >> 11566872

Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.

R M Barron1, V Thomson, E Jamieson, D W Melton, J Ironside, R Will, J C Manson.   

Abstract

The PrP gene of the host exerts a major influence over the outcome of transmissible spongiform encephalopathy (TSE) disease, but the mechanism by which this is achieved is not understood. We have introduced a specific mutation into the endogenous murine PrP gene using gene targeting to produce transgenic mice with a single amino acid alteration (proline to leucine) at amino acid position 101 in their PrP protein (P101L). The effect of this alteration on incubation time, targeting and PrP(Sc) formation has been studied in TSE-infected animals. Transgenic mice carrying the P101L mutation in PrP have remarkable differences in incubation time and targeting of central nervous system pathology compared with wild-type littermates, following inoculation with infectivity from human, hamster, sheep and murine sources. This single mutation can alter incubation time across three species barriers in a strain-dependent manner. These findings suggest a critical role for the structurally 'flexible' region of PrP in agent replication and targeting of TSE pathology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566872      PMCID: PMC125625          DOI: 10.1093/emboj/20.18.5070

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  57 in total

Review 1.  Prion protein and the transmissible spongiform encephalopathy diseases.

Authors:  B Chesebro
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Membrane environment alters the conformational structure of the recombinant human prion protein.

Authors:  M Morillas; W Swietnicki; P Gambetti; W K Surewicz
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

3.  Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.

Authors:  Z F Kanyo; K M Pan; R A Williamson; D R Burton; S B Prusiner; R J Fletterick; F E Cohen
Journal:  J Mol Biol       Date:  1999-11-05       Impact factor: 5.469

Review 4.  The prion folding problem.

Authors:  P M Harrison; P Bamborough; V Daggett; S B Prusiner; F E Cohen
Journal:  Curr Opin Struct Biol       Date:  1997-02       Impact factor: 6.809

5.  Recombinant scrapie-like prion protein of 106 amino acids is soluble.

Authors:  T Muramoto; M Scott; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

6.  Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.

Authors:  M R Scott; R Will; J Ironside; H O Nguyen; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy.

Authors:  J C Manson; E Jamieson; H Baybutt; N L Tuzi; R Barron; I McConnell; R Somerville; J Ironside; R Will; M S Sy; D W Melton; J Hope; C Bostock
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

8.  NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231).

Authors:  R Riek; S Hornemann; G Wider; R Glockshuber; K Wüthrich
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

9.  Recombinant full-length murine prion protein, mPrP(23-231): purification and spectroscopic characterization.

Authors:  S Hornemann; C Korth; B Oesch; R Riek; G Wider; K Wüthrich; R Glockshuber
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

10.  Prion protein expression in different species: analysis with a panel of new mAbs.

Authors:  G Zanusso; D Liu; S Ferrari; I Hegyi; X Yin; A Aguzzi; S Hornemann; S Liemann; R Glockshuber; J C Manson; P Brown; R B Petersen; P Gambetti; M S Sy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  42 in total

1.  Grand ideas floating freely. Conference on the new prion biology: basic science, diagnosis and therapy.

Authors:  Bruce Chesebro
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

Review 2.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

3.  Structure of the β2-α2 loop and interspecies prion transmission.

Authors:  Cyrus Bett; Natalia Fernández-Borges; Timothy D Kurt; Melanie Lucero; K Peter R Nilsson; Joaquín Castilla; Christina J Sigurdson
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

4.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

5.  Correlation analysis for the incubation period of prion disease.

Authors:  Se-Eun Bae; Sunghoon Jung; Ha-Yeon Kim; Hyeon S Son
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

6.  Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease.

Authors:  Silvio Notari; Rosaria Strammiello; Sabina Capellari; Armin Giese; Maura Cescatti; Jacques Grassi; Bernardino Ghetti; Jan P M Langeveld; Wen-Quan Zou; Pierluigi Gambetti; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

7.  Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.

Authors:  Brent Race; Katie Phillips; Kimberly Meade-White; James Striebel; Bruce Chesebro
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

8.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

9.  Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype.

Authors:  Charles Grose; Shaun Tyler; Geoff Peters; Joanne Hiebert; Gwen M Stephens; William T Ruyechan; Wallen Jackson; Johnathan Storlie; Graham A Tipples
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification.

Authors:  Piero Parchi; Rosaria Strammiello; Silvio Notari; Armin Giese; Jan P M Langeveld; Anna Ladogana; Inga Zerr; Federico Roncaroli; Patrich Cras; Bernardino Ghetti; Maurizio Pocchiari; Hans Kretzschmar; Sabina Capellari
Journal:  Acta Neuropathol       Date:  2009-08-29       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.